S 30972-1

• CAT Number: I035885
• CAS Number: 209617-63-0
• Molecular Formula: C27H32Cl2N4O5
• Molecular Weight: 563.48
• Purity: 98%
• Synonyms: S 30972-1; S30972-1; S-30972-1
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: 5-[1-[2-(dimethylamino)ethylcarbamoyl]-5,6-dimethylpyrido[4,3-b]carbazol-9-yl]oxy-5-oxopentanoic acid;dihydrochloride
• InChI: InChI=1S/C27H30N4O5.2ClH/c1-16-18-10-11-28-25(27(35)29-12-13-30(2)3)20(18)15-21-19-14-17(8-9-22(19)31(4)26(16)21)36-24(34)7-5-6-23(32)33;;/h8-11,14-15H,5-7,12-13H2,1-4H3,(H,29,35)(H,32,33);2*1H
• InChIKey: NSBSOMWCNYNCBD-UHFFFAOYSA-N
• SMILES: CC1=C2C=CN=C(C2=CC3=C1N(C4=C3C=C(C=C4)OC(=O)CCCC(=O)O)C)C(=O)NCCN(C)C.Cl.Cl

S 30972-1（Cat No.:I035885）is a small-molecule inhibitor designed to target and modulate the activity of specific proteins involved in cellular signaling pathways. It has shown potential in preclinical studies for its ability to disrupt key pathways that contribute to cancer cell proliferation, survival, and metastasis. S 30972-1’s precise mechanism of action is often linked to the inhibition of kinases or other regulatory proteins that play a critical role in oncogenesis. It is being explored for its therapeutic potential in treating various cancers, particularly those resistant to conventional therapies. Further clinical studies are needed to establish its efficacy.